# EDGAR Filing Document

**Accession Number:** 0001114448
**File Stem:** 0001114448-26-000008
**Filing Date:** 2026-2
**Character Count:** 2460
**Document Hash:** 8d89d9a28d43f0114d587f7a0843030e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001114448-26-000008.hdr.sgml**: 20260204

**ACCESSION NUMBER**: 0001114448-26-000008

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260204

**DATE AS OF CHANGE**: 20260204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NOVARTIS AG
- **CENTRAL INDEX KEY:** 0001114448
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15024
- **FILM NUMBER:** 26595986

**BUSINESS ADDRESS:**
- **STREET 1:** LICHTSTRASSE 35
- **CITY:** BASEL
- **STATE:** V8
- **ZIP:** CH 4056
- **BUSINESS PHONE:** 01141613241111

**MAIL ADDRESS:**
- **STREET 1:** LICHTSTRASSE 35
- **CITY:** BASEL
- **STATE:** V8
- **ZIP:** CH 4056

------

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 or 15d-16 OF**

**THE SECURITIES EXCHANGE ACT OF 1934**

 **Report on Form 6-K dated February 4, 2026**

**(Commission File No. 1-15024)**

------

**Novartis AG**

(Name of Registrant)

**Lichtstrasse 35**

**4056 Basel**

**Switzerland**

(Address of Principal Executive Offices)

------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

---

| | |
|:---|:---|
| **Form 20-F: ☒** | Form 40-F: ☐ |

---

------

------

**Exhibits:**

<br> [99.1 Annual Report 2025](a260204-99_1.pdf)

[99.2 Report on Nonfinancial Matters 2025](a260204-99_2.pdf) <br>

**** 

<br> **SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **Novartis AG** | **Novartis AG** | **Novartis AG** |
| Date: February 4, 2026 | By: | /s/ PAUL PENEPENT | /s/ PAUL PENEPENT |
|  | Name: | Name: | Paul Penepent |
|  | Title: | Title: | Head Financial Reporting and Accounting |

---

------

### Attached PDF Documents

**Attachment 1:** `a260204-99_1.pdf`

_No text found in this document._

**Attachment 2:** `a260204-99_2.pdf`

_No text found in this document._